Top Markets
Coin of the day
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd.

PIQ
Rang in Aktien #30007
Proteomics International Laboratories Ltd operates as a medical technology... Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia. It provides PromarkerD, a blood test to predict diabetic kidney disease (DKD). The company’s products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, which has completed clinical validation trials for esophageal cancer diagnosis; and OxiDx (2-tag), which has completed clinical validation phase for oxidative stress treatment. It is also developing diagnostic tests for that includes DKD - T1D, that is under clinical phase for type 1 diabetes, diabetic retinopathy, and diabetic neuropathy; Asthma and COPD, which has completed proof-of-concept study trials for asthma and chronic obstructive pulmonary disease; Plant Dieback, that is under development phase for phytophthora dieback; Diabetic Retinopathy, which has completed discovery phase for sight-threatening retinopathy; and Diabetic Neuropathy, that is under research phase to investigate predictive biomarkers for diabetic neuropathy. The company also offers analytical services, such as specialist contract research focusing on biomarker discovery, biosimilars quality control, and pharmacokinetic testing for clinical trials. It has strategic collaboration with Harry Perkins Institute of Medical Research, Bioplatforms Australia, The University of Western Australia, Australian Research Council Training Centre, and the Australian Centre. Proteomics International Laboratories Ltd was founded in 2001 and is based in Perth, Australia.
Aktienkurs
$0.11284557
Marktkapitalisierung
$18.66M
Veränderung (1 Tag)
3.23%
Veränderung (1 Jahr)
-47.82%
Land
AU
Handel Proteomics International Laboratories Ltd. (PIQ)

Kategorie

Preis PIQ mit Marktkapitalisierung von B
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.
PIQ
$0.11284557
Marktkapitalisierung von Proteomics International Laboratories Ltd.(PIQ)
Marktkapitalisierung: $18.66M
Mit Stand August 2026 hat Proteomics International Laboratories Ltd. eine Marktkapitalisierung von $18.66M. Das macht Proteomics International Laboratories Ltd. laut unseren Daten zum 30007th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Proteomics International Laboratories Ltd. von 2014 bis 2026
PIQ im Vergleich zu den Top 5 der beliebtesten stocks
Preis für PIQ Vermögenswert B Marktkapitalisierung von B Ergebnisse
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.
$32,088.55 $18.66M
$5.307T +28,435,704.94%
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.
$27,517.98 $18.66M
$4.551T +24,385,419.63%
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.
$25,121.16 $18.66M
$4.154T +22,261,442.80%
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.
$21,699.71 $18.66M
$3.589T +19,229,461.09%
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.
$16,912.35 $18.66M
$2.797T +14,987,064.10%